 | A major contributor to this section appears to have a close connection with its subject. (May 2023) |
 | |
| Company type | KGaA with Aktiengesellschaft as partner with unlimited liability |
|---|---|
| FWB: FME FWB: FMEA (ADR) OTC Pink Current: FMCQF NYSE: FMS (ADR) MDAX component (FME) | |
| ISIN | DE0005785802 US3580291066 |
| Industry | Health care |
| Founded | 1996 |
| Headquarters | Bad Homburg vor der Höhe, Germany |
Key people | Helen Giza (CEO, Chair of the management board and acting CFO) Dieter Schenk (Chairman of the supervisory board) |
| Products | Dialysis products and services, Therapeutic Apheresis Products |
| Revenue | €19.40 billion (2022) |
| €1.51 billion (2022) | |
| €0.67 billion (2022) | |
| Total assets | €34,367 million (2021) |
| Total equity | €13,979 million (2021) |
| Owner | Fresenius (32%) |
Number of employees | 128,000 (2022)[1] |
| Website | www |
| Footnotes / references [2][3] | |
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients.[3] The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.[4]
The company is 32% owned by Fresenius[5] and, as of 2020, generates around 50% of the group's revenue.[6]
The company is on the Best Employers List published by Forbes.[7]
- ^ "Company Profile". Retrieved March 20, 2023.
- ^ "SEC filing Form 20-F". U.S. Securities and Exchange Commission. 25 February 2019.
- ^ a b "Annual Report 2021" (PDF). Fresenius Medical Care.
- ^ "Annual Report 2019" (PDF). Fresenius Medical Care.
- ^ "Shareholder structure". Fresenius Medical Care.
- ^ Zuzanna Szymanska (February 20, 2020), Fresenius forecasts 2020 profit growth driven by drug, dialysis units Reuters.
- ^ "Fresenius Medical Care". Forbes.